Pharmacy Times
NOVEMBER 21, 2023
Christian John Lillis, co-founder and executive director at Peggy Lillis Foundation, discusses the role of the pharmacist in education that advances C diff awareness in the medical community.
Drug Topics
NOVEMBER 24, 2023
Study authors recommend that healthcare personnel consider prioritizing influenza vaccination for patients with recent cardiovascular diseases (CVDs) in light of new evidence.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
NOVEMBER 24, 2023
Reports this week that China is experiencing a surge in respiratory infections in young children triggered flashbacks of the start of the Covid-19 pandemic among infectious disease watchers. But a rapidly organized meeting Thursday between the World Health Organization and health officials in China assuaged much of that concern. The evidence presented to the WHO team pointed to what’s sometimes called an immunity gap that was created by the pandemic.
Fierce Pharma
NOVEMBER 21, 2023
With litigation spanning many countries, the COVID-19 vaccine giants remain engaged in a heated patent war. | Moderna pledged to appeal after the European Patent Office ruled one of its patents invalid in the intellectual property battle that spans multiple countries.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
NOVEMBER 21, 2023
Zavegepant (Zavzpret; Pfizer) is the first and only only CGRP receptor antagonist as a nasal spray for the acute treatment of migraine in adults with and without aura approved by the FDA.
Drug Topics
NOVEMBER 24, 2023
Reproductive-aged women who consume energy drinks should be aware of the potential risks, as energy drink consumption has been linked to adverse pregnancy outcomes.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Pharma
NOVEMBER 21, 2023
The U.S. Federal Trade Commission isn’t letting up in its effort to crack down on pharma’s alleged misuse of a patent mechanism in the FDA’s regulatory process. | The U.S. Federal Trade Commission isn't letting up in its effort to crack down on pharma's alleged misuse of a patent mechanism in the FDA's regulatory process. And it's Sanofi’s turn to land in the crosshairs.
Pharmacy Times
NOVEMBER 20, 2023
The results suggest that telemedicine could be used to help improve access for other populations that might be stigmatized, beyond hepatitis C virus and opioid use disorder.
Drug Topics
NOVEMBER 20, 2023
Rich in polyphenolic compounds like chlorogenic acid (CGA), coffee may help ward off COVID-19 infection in the post-pandemic era.
STAT
NOVEMBER 24, 2023
UnitedHealth Group’s Optum division is already the largest employer of physicians in the United States, but allegations in a new lawsuit suggest Optum is hungry for more. Emanate Health, a nonprofit group of hospitals and physicians in California, filed a federal lawsuit Monday, alleging Optum pushed it to agree not to compete for primary care physicians, a violation of antitrust law.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
NOVEMBER 21, 2023
Navigating the healthcare system often requires using different websites, mobile apps and phone calls to find providers and make appointments. | The health system has seen a 10x increase in downloads of the Prisma Health Go app, from 40 to up to 400 downloads per day. The health system also reports a 33% reduction in patient no-shows in one year and estimates $8 million in cost savings as a result of slashing the no-show rates.
Pharmacy Times
NOVEMBER 24, 2023
For pharmacists and pharmacy technicians, who work diligently to ensure our health and well-being, choosing the perfect holiday gift can be a thoughtful way to express gratitude and brighten their season.
Drug Topics
NOVEMBER 21, 2023
Black patients reported associating negative emotions with experiences of racial discrimination long after the experience concluded, raising concerns about long-term health outcomes.
STAT
NOVEMBER 22, 2023
In 2009, I was practicing in the emergency department when the H1N1 pandemic emerged. Then, I saw firsthand the vital role infectious disease physicians played in not only facilitating a coordinated public health response, but also helping patients, providers, and the public navigate the uncertainty that comes with confronting a novel virus. While on the frontlines of that pandemic, I depended on our community’s infectious disease specialists as I worked in real-time to provide patients w
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
NOVEMBER 22, 2023
Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing production of diabetes drug Victo | Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing production of diabetes drug Victoza to make more Ozempic.
Pharmacy Times
NOVEMBER 22, 2023
Denise Giambalvo, director of Member Engagement & Business Strategy at the Washington Health Alliance and recently led a biosimilars initiative for the coalition, discusses biosimilar influence of pricing for biologic drugs, trends to expect in 2024, and why education on biosimilars are important for patients, pharmacists, prescribers, and more
Drug Topics
NOVEMBER 22, 2023
Increased health care access to devices like the continuous glucose monitor (CGM) could improve health outcomes for underserved patients who may otherwise be hindered from their use.
STAT
NOVEMBER 20, 2023
In the depths of the Covid-19 pandemic, something strange happened: For a year or two, illnesses that used to emerge like clockwork when fall and winter arrived — flu, RSV, and the myriad viruses that cause colds — did not sicken us. The cause now appears clear: The measures we took to avoid the new disease, including isolating and social distancing, muscled most other respiratory pathogens out of the cold-and-flu-season picture.
Fierce Pharma
NOVEMBER 22, 2023
Pfizer, working through a $3.5 billion cost-cutting drive, is not done yet making changes to its workforce in Ireland. | Pfizer's commercial office in Citywest, Dublin, will move to its Ringsend office building, the Irish Independent reports. The moves could end in more job cuts in the company's commercial division.
Pharmacy Times
NOVEMBER 21, 2023
Paul Feuerstadt, MD, FACG, AGAF, discusses insights in current treatment practices for CDI at the Peggy Lillis Foundation’s 2023 State of C diff Virtual Town Hall.
Fierce Healthcare
NOVEMBER 20, 2023
Traditional Medicare paid out an estimated $31.2 billion in improper payments in fiscal year 2023, according to new data from the federal government. | The Centers for Medicare & Medicaid Services released its annual look at improper payments and found that the overall rate in Medicare was 7.38%, which sits below the 10% level mandated in statute.
STAT
NOVEMBER 18, 2023
The revolution started in silence. Jennifer Doudna and Emmanuelle Charpentier, now Nobelists , published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science.
Fierce Pharma
NOVEMBER 21, 2023
Texas has accused Pfizer and manufacturer Tris Pharma of knowingly providing compromised ADHD medicine to a state Medicaid program for children of low-income families. | In its lawsuit, Texas says the companies knew that deficient manufacturing processes compromised the effectiveness of Quillivant XR. The lawsuit further accuses the companies of manipulating quality-control testing from 2012 to 2018 to ensure samples received passing grades.
Pharmacy Times
NOVEMBER 22, 2023
The designation allows expedited development of ADP101 as a treatment for food allergy in children ages 4 to 17 with confirmed allergy to 1 or more of the 15 foods in the drug product.
Fierce Healthcare
NOVEMBER 22, 2023
Open enrollment on the insurance marketplaces began on Nov. | Open enrollment on the insurance marketplaces began on Nov. 1, and more than 4.5 million people have selected plans in the early weeks of the process, according to new federal data.
STAT
NOVEMBER 20, 2023
Cell and gene therapies are the next frontier in medicine and promise long-sought hope for people living with incurable and fatal conditions. As their promise increasingly becomes reality, the FDA’s gatekeeping role is important. To truly serve the people who need these medications, the FDA must be a good-faith partner and deploy the tools my fellow congressional lawmakers and I helped secure.
Pharmaceutical Technology
NOVEMBER 21, 2023
Texas AG has sued Pfizer and Tris Pharma for providing adulterated attention-deficit/hyperactivity disorder drug, Quillivant XR, to children.
Pharmacy Times
NOVEMBER 22, 2023
Serotype 19A is still the most prevalent serotype for pneumococcal disease, with study authors calling for additional studies to determine the full burden of invasive pneumococcal disease.
Fierce Healthcare
NOVEMBER 22, 2023
Ayble Health, a digital health platform for patients with chronic gastrointestinal conditions, has announced a new collaboration with the Mayo Clinic. | Ayble is working with the Mayo Clinic Complex Care Program to offer a hybrid care model to match patients with the appropriate virtual and in-person care based on acuity and need.
STAT
NOVEMBER 21, 2023
The leadership turmoil within OpenAI, the maker of ChatGPT, is triggering calls for stepped-up efforts to establish standards for how generative AI is used across the health care industry, where experts worry that one or two companies could end up with too much control. Microsoft was already a driving force behind efforts to deploy generative AI in health care.
Fierce Pharma
NOVEMBER 22, 2023
Looking to protect its lucrative immunology drug Rinvoq, AbbVie is suing a clutch of generic drug makers that are attempting to market copycat versions of the blockbuster. | In a lawsuit filed in Delaware federal court Monday, AbbVie accused Sandoz, Hetero Labs, Aurobindo Pharma, Intas Pharmaceuticals and Sun Pharmaceutical of trying to sidestep dozens of patents protecting Rinvoq through the next decade.
Pharmacy Times
NOVEMBER 22, 2023
Use of both nutrition and treatment can help children and elderly populations, especially those in developing countries where vaccine availability is limited.
Fierce Healthcare
NOVEMBER 22, 2023
Memorial Hermann Health System is implementing Laudio’s platform to enhance employee efficiency and engagement. | Memorial Hermann Health System is tapping Laudio’s AI platform to promote efficiency and engagement among its employees.
STAT
NOVEMBER 21, 2023
Pharmacies could be called the most “rock solid” entity in our health care system. Even before Covid, pharmacies were held in high esteem; during the pandemic, they raised their game by making it easy for tens of millions of Americans to get vaccinated, fulfilling a long-standing ambition of pharmacists to provide more expansive clinical services.
Expert insights. Personalized for you.
158 
Let's personalize your content